AC Immune SA (IMR) Stock Statistics & Valuation Metrics

AC Immune SA has a market cap or net worth of €269.48M. The enterprise value is €239.96M.

AC Immune SA has 98,943,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

AC Immune SA’s return on equity (ROE) is -1.50 and return on invested capital (ROIC) is -108.89%.

The current PE Ratio of AC Immune SA is ―. AC Immune SA’s PEG ratio is -0.12.

In the last 12 months, AC Immune SA had revenue of 3.41M and earned -67.28M in profits. Earnings per share was -0.67.

In the last 12 months, operating cash flow was -69.20M and capital expenditures -900.16K, giving a free cash flow of -70.10M billion.

AC Immune SA pays an annual dividend of ―, resulting in a dividend yield of ―

AC Immune SA upcoming earnings date is Apr 23, 2026, TBA (Confirmed).

AC Immune SA as a current ratio of 1.02, with Debt / Equity ratio of 10.12%

In the past 12 months, AC Immune SA has paid 0.00 in taxes.

AC Immune SA EV to EBITDA ratio is -3.60, with an EV/FCF ratio of -3.41.

AC Immune SA has €91.52M in cash and marketable securities with €4.55M in debt, giving a net cash position of €86.97M billion.

Gross margin is 94.80%, with operating margin of -1929.95%, and net profit margin of -1971.65%.

The average price target for AC Immune SA is €8.70, which is 11.43% higher than the current price. The consensus rating is Moderate Buy